Novo's Ozempic Pill Fails in Alzheimer's Effort
Novo Nordisk shares PLUNGE after announcing that a pill version of Ozempic failed to slow the progression of Alzheimer's disease in two late-stage studies. Bloomberg's Madison Muller discusses the story...
By Bloomberg Markets · Bloomberg Markets
Novo Nordisk shares PLUNGE after announcing that a pill version of Ozempic failed to slow the progression of Alzheimer's disease in two late-stage studies. Bloomberg's Madison Muller discusses the story on "Bloomberg Markets" with Scarlet Fu. (Source: Bloomberg)